Oral application of freeze-dried yeast particles expressing the PCV2b Cap protein on their surface induce protection to subsequent PCV2b challenge in vivo. (2015)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2015.10.003
PubMed Identifier: 26476879
Publication URI: http://europepmc.org/abstract/MED/26476879
Type: Journal Article/Review
Volume: 33
Parent Publication: Vaccine
Issue: 46
ISSN: 0264-410X